Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 57Hodgkin Disease 55Multiple Myeloma 54Myelodysplastic Syndromes 52Leukemia 45Lymphoma, Mantle-Cell 42Lymphoma, Follicular 39Lymphoma, Large B-Cell, Diffuse 36Lymphoma 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Myeloproliferative Disorders 32Leukemia, Myelomonocytic, Chronic 31Burkitt Lymphoma 31Congenital Abnormalities 28Lymphoma, Large-Cell, Immunoblastic 27Waldenstrom Macroglobulinemia 26Leukemia, Myeloid, Chronic-Phase 25Leukemia, Myeloid, Accelerated Phase 23Lymphoma, T-Cell, Cutaneous 21Recurrence 20Primary Myelofibrosis 20Lymphoma, Large-Cell, Anaplastic 19Dendritic Cell Sarcoma, Interdigitating 19Hematologic Neoplasms 18Blast Crisis 18Anemia, Refractory, with Excess of Blasts 18

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Standard of Care 1Melphalan 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metabolism, Inborn Errors × Whole-Body Irradiation × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡